Kansas City Cancer Center

Area cancer centers complete merger

The University of Kansas Cancer Center and Kansas City Cancer Center have completed their merger.

The organization will have 52 medical and radiation oncologists working in 12 locations throughout the Greater Kansas City area. The combined organization will be part of The University of Kansas Cancer Center, but the KCCC neighborhood cancer centers will connect both the center names in one logo, building on the strengths of both community known organizations.

The combined organization will maintain KCCC’s existing relationships with community hospitals around the area.

“Two organizations with the same ‘patient first’ culture are now one, with multiple options for patients,” said Bob Page, president and chief executive officer of The University of Kansas Hospital. “Our existing academic medical center model will continue, as will KCCC’s neighborhood practices with their multiple community hospital relationships.

“Patients throughout the region will have greater access to cancer physicians and unparalleled access to clinical trials and sub-specialists in many cancer disciplines. It’s an historic time in the fight against cancer.”

No jobs will be lost as a result of the merger.

Twenty-seven physicians from Kansas City Cancer Center become members of the University of Kansas School of Medicine faculty in Internal Medicine and in Radiation Oncology. The new faculty eventually will be involved in clinical education of students and residents. Non-physician staff members of KCCC are now employees of The University of Kansas Hospital.

Research will continue to be one of the primary missions of the merged organization. The group begins with 143 clinical trials under way from The University of Kansas Cancer Center and 73 from U.S. Oncology and KCCC for a total of 216. Leaders of the combined organization say they will build upon this number with new early phase clinical trials emerging from The University of Kansas Cancer Center.

U.S. Oncology will have the option of promoting the locally generated trials throughout its national network of physicians. Local patients will continue to have access to U.S. Oncology clinical research trials.

U.S. Oncology will continue to provide key software to the new operation, including its evidence-based clinical pathways program.

The Star's editorial | Grants, merger are good ... - KansasCity.com

Two announcements in as many weeks are good news for the Kansas City region&#x92;s quest to increase its standing in the realm of medical and scientific research.</p><p>The most recent is the merger of two institutions that specialize in the fight against cancer. The University of Kansas Cancer Center &#x97; a research, teaching and clinical program &#x97; is joining forces with Kansas City Cancer Center, a community-based treatment group. </p><p>The merger will give cancer patients access to an expanded selection of physicians, specialists, clinical trials and treatment approaches. </p><p>It also is expected to boost the prospects for the KU Cancer Center to be named a designated cancer center by the National Cancer Institute.</p><p> It took about 18 months to iron out the details of the complex merger with the Kansas City Cancer Center. Both sides should be commended for working together for the good of the region and scientific research.</p><p>The University of Kansas Medical Center announced last week it will receive $20 million in the form of a Clinical and Translational Science Award from the National Institutes of Health.</p><p> The award will be used to speed up the process of converting medical research into marketable treatments that will help patients.</p><p>Also, an anonymous donor was impressed enough with the medical center&#x92;s spinal cord research to give $4 million to its Institute of Neurological Disorders.</p><p> Like the larger NIH grant, it is a welcome recognition of good work.

Two announcements in as many weeks are good news for the Kansas City region’s quest to increase its standing in the realm of medical and scientific research.

The most recent is the merger of two institutions that specialize in the fight against cancer. The University of Kansas Cancer Center — a research, teaching and clinical program — is joining forces with Kansas City Cancer Center, a community-based treatment group.

The merger will give cancer patients access to an expanded selection of physicians, specialists, clinical trials and treatment approaches.

It also is expected to boost the prospects for the KU Cancer Center to be named a designated cancer center by the National Cancer Institute.

It took about 18 months to iron out the details of the complex merger with the Kansas City Cancer Center. Both sides should be commended for working together for the good of the region and scientific research.

Merger Complete for The University of Kansas Cancer Center and Kansas City Cancer Center

Merger Complete for The University of Kansas Cancer Center and Kansas City Cancer Center

Cancer care for the whole patient, meeting psychosocial health needs

... PhD, FAAN, at the City of Hope National Medical Center; Ethan Gray and Kathryn ... and Barbara Adkins, MS, ARNP-BC, AOCNP, at Kansas City Cancer Center ; ...

Congressional Record

He and his wife, Annette, founded the RA Bloch Cancer Management Center and the RA Bloch Cancer Support Center at the University of Missouri, Kansas City, ...

Cancer research

... Pittsburgh, Pennsylvania and 'Stowers Institute for Medical Research, Kansas City, ... Room 2.42d, Hillman Cancer Center. 5117 Center Avenue. ...

Individual, family, and community, promoting and restoring health and well-being

Kathleen A. Ducey, RN, MS, OCN, Nurse Manager, University of Kansas Cancer Center, Kansas City, KS 66160. Angela M. Sears, RN, MS, OCN, Nurse Clinician, ...

Insiders' Guide to Kansas City

The Cancer Institute (913)676-8156 This oncology partnership, affiliated with Saint ... The institute collaborates with Kansas City's academic and research ...